PA HB 622
in committeeAn Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for prohibited acts and penalties.
Pennsylvania · 2025-2026 Regular Session (209th General Assembly) · lower
Quick answers
Did PA HB 622 pass?
Not yet. PA HB 622 is in committee as of 2025-02-20 and has not come to a final vote. Latest recorded action (2025-02-20): Referred to Judiciary
What is PA HB 622 about?
PA HB 622 is a bill in the 2025-2026 Regular Session (209th General Assembly) titled “An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for prohibited acts and penalties.”.
Who sponsors PA HB 622?
Doyle Heffley is the primary sponsor of PA HB 622, joined by 8 cosponsors.
- Introduced
- —
- Latest action
- 2025-02-20 — Referred to Judiciary
- Bill type
- bill
- Last updated
- —
Sponsors
- Doyle Heffleyprimary
- Louis Schmittcosponsor
- Andrew Kuzmacosponsor
- Bud Cookcosponsor
- Brian Smithcosponsor
- Dane Watrocosponsor
- R. Lee Jamescosponsor
- David Zimmermancosponsor
- Mark Gillencosponsor
Committees
Not provided by source.
Action timeline
2025-02-20
Referred to Judiciary
referral-committee
Versions
- Printer's No. PN0633Compare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:31:13.705233Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=PA&identifier=HB 622. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.